Selected article for: "membrane receptor binding and spike glycoprotein"
Author: Saxena, Shailendra K.; Kumar, Swatantra; Baxi, Preeti; Srivastava, Nishant; Puri, Bipin; Ratho, R. K.
Title: Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
  • Cord-id: aopws8ze
  • Document date: 2020_12_5
    • ID: aopws8ze
    Snippet: An ongoing pandemic Coronavirus disease (COVID-19), caused by a newly emerged Coronavirus, SARS-CoV-2 has affected millions of people globally. One of the most crucial structural proteins of SARS-CoV-2 is the Spike glycoprotein (S-glycoprotein), for which the first de novo modelling was envisaged by our group in early 2020, and was superimposed to its predecessor SARS-CoV S-glycoprotein, to determine structural divergence, glycosylation and antigenic variation between SARS-CoV-2 and SARS-CoV. S-
    Document: An ongoing pandemic Coronavirus disease (COVID-19), caused by a newly emerged Coronavirus, SARS-CoV-2 has affected millions of people globally. One of the most crucial structural proteins of SARS-CoV-2 is the Spike glycoprotein (S-glycoprotein), for which the first de novo modelling was envisaged by our group in early 2020, and was superimposed to its predecessor SARS-CoV S-glycoprotein, to determine structural divergence, glycosylation and antigenic variation between SARS-CoV-2 and SARS-CoV. S-glycoprotein is involved in binding with the cellular receptor, membrane fusion, internalization via angiotensin-converting enzyme 2 (ACE2) receptor, and tissue tropism. Upon internalization into the target host cells, the viral genome encodes two precursor polypeptides which get processed into 16 mature nonstructural proteins that play a crucial role in replication and transcription of SARS-CoV-2. Currently S-glycoprotein is one of the most vital targets for vaccine and therapeutics development for COVID-19.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory structural and acute injury: 1
    • accessory structural and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory structural and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory structural protein and acute respiratory: 1, 2, 3, 4, 5
    • accessory structural protein and acute respiratory syndrome: 1, 2, 3, 4, 5
    • ace function and acute injury: 1, 2
    • ace function and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • ace function and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • activation attachment and acute injury: 1
    • activation attachment and acute respiratory: 1
    • activation proteolytic cleavage and acute respiratory: 1, 2, 3, 4, 5
    • activation proteolytic cleavage and acute respiratory syndrome: 1, 2, 3, 4, 5
    • acute respiratory and adjacent cell: 1, 2
    • acute respiratory and long polyprotein: 1, 2
    • acute respiratory and lysine residue: 1, 2, 3, 4, 5
    • acute respiratory syndrome and adjacent cell: 1, 2
    • acute respiratory syndrome and long polyprotein: 1